Get the Stockscreener App
0.86
1.71%
-0.015
After Hours:
.85
-0.01
-1.16%
Sutro Biopharma Inc stock is traded at $0.86, with a volume of 473.71K.
It is down -1.71% in the last 24 hours and down -18.10% over the past month.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
See More
Previous Close:
$0.875
Open:
$0.88
24h Volume:
473.71K
Relative Volume:
0.52
Market Cap:
$73.22M
Revenue:
$153.73M
Net Income/Loss:
$-106.79M
P/E Ratio:
-0.4831
EPS:
-1.78
Net Cash Flow:
$-115.93M
1W Performance:
-3.37%
1M Performance:
-18.10%
6M Performance:
-6.52%
1Y Performance:
-67.05%
1-Day Range:
$0.8431
$0.8927
1-Week Range:
$0.81
$0.946
52-Week Range:
$0.5231
$3.01
Sutro Biopharma Inc Stock (STRO) Company Profile
Name
Sutro Biopharma Inc
Sector
Industry
Phone
650-392-8412
Address
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Compare STRO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
0.86 | 74.49M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-16-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-17-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-14-25 | Downgrade | BofA Securities | Buy → Underperform |
| Mar-14-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Mar-14-25 | Downgrade | Wedbush | Outperform → Neutral |
| May-08-24 | Initiated | BofA Securities | Buy |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-06-23 | Initiated | Oppenheimer | Outperform |
| Mar-21-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-18-22 | Resumed | Wells Fargo | Overweight |
| Jun-18-21 | Initiated | H.C. Wainwright | Buy |
| Dec-03-20 | Initiated | Stifel | Buy |
| Sep-02-20 | Initiated | Jefferies | Buy |
| Jul-16-20 | Initiated | Wells Fargo | Overweight |
| Jan-13-20 | Initiated | SunTrust | Buy |
| Oct-07-19 | Initiated | BTIG Research | Buy |
| Jul-18-19 | Initiated | Deutsche Bank | Buy |
| Apr-29-19 | Initiated | H.C. Wainwright | Buy |
| Oct-22-18 | Initiated | JMP Securities | Mkt Outperform |
| Oct-22-18 | Initiated | Piper Jaffray | Overweight |
| Oct-22-18 | Initiated | Wedbush | Outperform |
View All
Sutro Biopharma Inc Stock (STRO) Latest News
Can Sutro Biopharma Inc. stock reach $100 price target2025 Top Decliners & Daily Profit Focused Screening - newser.com
How reliable is Sutro Biopharma Inc. (S09) stock dividend growthMarket Sentiment Summary & AI Based Trade Execution Alerts - newser.com
Why Sutro Biopharma Inc. stock attracts global investorsSwing Trade & High Conviction Investment Ideas - newser.com
Statistical indicators supporting Sutro Biopharma Inc.’s strengthWeekly Investment Summary & Consistent Income Trade Ideas - newser.com
Can Sutro Biopharma Inc. recover in the next quarterPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Applying big data sentiment scoring on Sutro Biopharma Inc.2025 Market WrapUp & Risk Controlled Daily Plans - newser.com
Can Sutro Biopharma Inc. (S09) stock sustain institutional flowsWeekly Profit Recap & Verified Technical Trade Signals - newser.com
Why Sutro Biopharma Inc. (S09) stock could break out in 2025 - newser.com
Can Sutro Biopharma Inc. (S09) stock hold up in economic slowdown2025 Pullback Review & Risk Managed Trade Strategies - newser.com
Volatility clustering patterns for Sutro Biopharma Inc.Market Risk Summary & Proven Capital Preservation Methods - newser.com
How to monitor Sutro Biopharma Inc. with trend dashboardsJuly 2025 Drop Watch & Daily Profit Focused Stock Screening - newser.com
Published on: 2025-11-19 12:47:09 - newser.com
Can technical indicators confirm Sutro Biopharma Inc.’s reversalJuly 2025 Snapshot & Smart Allocation Stock Tips - newser.com
What earnings margins imply for Sutro Biopharma Inc. (S09) stockJuly 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
Citizens reiterates Market Perform rating on Sutro Biopharma stock By Investing.com - Investing.com Canada
Published on: 2025-11-17 02:05:50 - newser.com
Published on: 2025-11-16 17:19:25 - newser.com
Applying Wyckoff theory to Sutro Biopharma Inc. stockPortfolio Value Summary & Growth Oriented Trade Recommendations - newser.com
Why Sutro Biopharma Inc. stock is considered a top pick2025 AllTime Highs & Safe Entry Point Alerts - newser.com
How buybacks impact Sutro Biopharma Inc. stock valueEarnings Beat & Technical Entry and Exit Alerts - newser.com
Sutro Biopharma Inc Stock (STRO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.53%
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):